NPPA REVISES 16 BULK DRUG PRICES

The National Pharmaceutical Pricing Authority (NPPA) has revised / fixed the prices of 16 drugs used to treat urinary tract infections, asthma and lung infections and anti-inflammatory drugs, and vitamins. It has also, for the first time, fixed the ceiling price of recombinant human insulin, scheduled bulk drugs including derivatives under the provisions of DPCO, 1995.

domain-B.com (http://www.domain-b.com/industry/pharma/20050920_prices.html)